significantly affect patient management decisions (16, 17) . These findings can include acute inflammation (18) and chronic disease without inflammation, which, if associated with proximal bowel distension, defines a fibrotic stricture (19, 20) . Furthermore, other MRE findings may include intra-abdominal complications such as fistulae, tethering (which may be the start of a fistula) and abscesses. There are a variety of T1W and T2W sequences to choose from, but the most useful for bowel imaging include the three-dimensional-gradient echo (3D GRE) T1W and the single-shot T2W techniques, as reviewed in detail previously (17) . T1W images are acquired after the administration of gadolinium-based contrast to selectively enhance the diseased bowel wall. Fat surrounds the bowel and can interfere with the visualization of the disease; inflamed bowel and fat both produce high signals on T2W and gadolinium-enhanced T1W images. Fat-suppression techniques are critical to improve disease conspicuity. The diseased bowel generates a high signal, which becomes highly conspicuous only if the adjacent fat is completely darkened by fat suppression (21) . T1W gadolinium-enhanced fat-suppressed and T2W single-shot images with and without fat suppression are the foundation for diagnosing and characterizing Crohn's disease. Regular T2W single-shot images depict bowel wall morphology. Fatsuppressed single-shot T2W images are critical to assess edema and inflammation related to active Crohn's disease, optimized with a spectral adiabatic inversion recovery (SPAIR) fatsuppression technique (22) .
Patient preparation before performing MRE can improve the results (16, 17, 23) . Oral, water-based contrast agents containing 2.5% mannitol, a non-digested carbohydrate, provide an osmotic load that slows water absorption (24) . The further addition of a viscous agent further improves small bowel distension. Between 1000 mL and 1200 mL of the water-based contrast can be given to the patient for oral ingestion 20 to 30 min prior to the examination, and 20 mg of metoclopramide or 100 mg of erythromycin can be given intravenously to MRE exams performed in combination with small bowel enteroclysis (MR-enteroclysis) (13) (14) (15) . This technique involves administering a large volume of fluid by an enteric tube and acquiring thick-section (5-8 cm) single-shot echo train spin-echo images with strong T2-weighting (T2W) to obtain images that resemble fluoroscopic small bowel images. Although both bright and dark lumen contrast agents have been proposed, water-based methods are relatively easy to implement and provide excellent signal characteristics, resulting in a bright lumen on T2W and a dark lumen on T1W techniques. To slow the absorption of the water that normally would occur rapidly in the jejunum, osmotic and viscosity agents are added. Some researchers, in the early development of MRE, have proposed the routine use of enteroclysis via a naso-jejunal tube for the administration of intra-luminal contrast to provide superior small bowel distension (14).
Currently, techniques for MRE emphasize sequences that are optimized to obtain findings that most promote gastric emptying. The addition of a rectal water enema provides improved visualization of the terminal ileum and may be considered an adjunct to facilitate the evaluation of the large bowel in addition to the small bowel (25, 26) . Prior to the motion-sensitive T1W 3D GRE sequences, 1 mg of glucagon may be administered intravenously to reduce artifacts from bowel peristalsis. A potential disadvantage of not performing MR-enteroclysis during MRE exams is suboptimal bowel distension. However, progressive experience over the past 10 years has led to the following conclusions, which contrast both with the early descriptions of MRE and with CT and fluoroscopy techniques: 1) By achieving significant improvements in the diagnostic quality of MRE sequence techniques, active and chronic disease states may be visualized even with suboptimal bowel lumen distention (27) . 2) These sequence techniques rely on T2W single-shot imaging, in combination with SPAIR for optimal fat suppression (22) , and T1W contrast-enhanced imaging, using the latest-generation 3D GRE, which achieves improved soft tissue contrast and edge sharpness. 3) An enteroclysis level of distention is often not necessary, and pre-procedure oral contrast is sufficient in most patients (28). 4) Routine water-based contrast agents used for CT are equally useful for MRE (17) . 5) Even if the patient is unwell and unable to take oral agents, the examination can proceed, and these studies can be frequently diagnostic in the setting of chronic or active Crohn's disease. Coronal (d) and axial (e) delayed-phase post-contrast T1W 3D GRE images show abnormal thickening and contrast uptake within the thickened wall of the terminal ileum (d, arrow), and these findings are compatible with active-on-chronic Crohn's disease and correspond to the histological equivalence of inflammation and submucosal fibrosis in this case. The terminal ileum was unable to be clearly identified on CT as separate from the right lower quadrant inflammatory process. This patient's data also demonstrate that on contrastenhanced CT imaging, it remains challenging to distinguish the anatomy in more complex cases and that it is not possible to reliably differentiate between acute and chronic inflammation and fibrosis. The MRI also preferentially shows other sequelae of Crohn's disease, with an extraluminal abscess (e, arrows) and phlegmon in the right lower quadrant, features that are not delineated from bowel loops on CT imaging. An extensive diagnostic evaluation with ultrasound, CT, colonoscopy with the terminal ileum biopsy and capsule endoscopy showed no abnormalities. The patient was diagnosed with irritable bowel syndrome based upon symptoms combined with exclusion of other considerations by objective studies. On further referral for continued symptoms, MRE was performed. Coronal precontrast (a) and delayed postcontrast (b) T1W 3D GRE images demonstrate a thickened, abnormally enhancing terminal ileum (arrows). Axial, fat-suppressed single-shot T2W image (c) demonstrating a minimally elevated T2 signal within the thickened wall of the terminal ileum (arrow) and no abnormal signal within the adjacent mesentery. Taken together, these findings concur with the predominance of fibrosis of the terminal ileum with minimal inflammatory changes, a pattern of chronic Crohn's disease. The clinical exam is characteristically nonspecific, and criteria for distinction between irritable bowel syndrome and irritable bowel disease, for example, rely on objective measures of disease. Optical endoscopy and endoscopic biopsy may be insensitive to disease restricted to the submucosa and deeper tissues. In this patient, the mucosa had presumably healed over the submucosal disease, a pattern that has been previously reported (28) . • Fistulae, tethering, and strictures ( Fig. 4 One important aspect of MRE interpretation is that active inflammation can mask underlying fibrosis related to chronic disease of the bowel wall ( Table 2) . The presence or absence of underlying fibrosis in this setting is of lesser immediate consequence as active inflammation that requires treatment. In the setting of active inflammation, longitudinal MRE evaluation is implemented to confirm improvements of active inflammation and to then evaluate the presence of unmasked chronic fibrotic disease. After therapy for active inflammation, the fibrotic burden can be assessed, and this information can be used for management decisions, including the need for surgery, as discussed later in this review (Figs. 1 and 2 ).
Clinical use of small bowel MRE
Techniques used to assess disease activity include endoscopy, capsule endoscopy, and/or surgical techniques in conjunction with tissue biopsy (29) (30) (31) (32) . However, these techniques are invasive (endoscopy) or may have contraindications (capsule endoscopy) in the setting of suspected bowel stenosis and obstruction. An underappreciated concern is that endoscopy and capsule endoscopy, and even endoscopy with biopsy, will evaluate only the extent of mucosal disease; as a result, submucosal and serosal-mesenteric disease will not be fully appreciated (17) .
MRE can be used for transmural small bowel evaluation. Prior studies have focused on the perfusion characteristics of the bowel wall after intravenous gadolinium administration to assess disease activity (33) .
The combination of T2W and T1W gadolinium-enhanced sequences can provide a high diagnostic accuracy in these patients (34) . Other authors have proposed an MRE-based scoring system for the assessment of inflammatory activity that includes features such as bowel wall thickening, lumen narrowing and the number of peri-intestinal lymph nodes (35). Although feasible, these evaluation algorithms are relatively demanding, which may ultimately limit clinical utilization. In particular, acquiring a series of carefully timed arterial-, venous-, and delayed-phase gadolinium-enhanced T1W images of the entire abdomen and pelvis will often require compromising the field of view at the top of the abdomen and result in sub-optimal assessment of the solid organs, including the liver. In addition, T1W images are more prone to technical complications from respiratory or bowel motion or from magnetic field distortions, as may result from surgical clips or bowel gas. Our experience has led us to propose a relatively simple approach for the evaluation of Crohn's disease activity using FS T2W single-shot fast spin-echo MRI (16, 17) . FS T2W imaging is sensitive to edema in or adjacent to the bowel wall (22) . Combining late vascular-or interstitial-phase gadolinium-enhanced T1W images with the FS T2W images allows for comprehensive evaluation and discrimination between quiescent disease and active inflammation (Figs.  1-3 ) and for the evaluation of complications, including abscesses, obstruction, and fistulae (Figs. 1, 4-8) .
The presence and magnitude of bowel wall edema correlates with active inflammation (36) (37) (38) . We have evaluated the accuracy of detecting abnormally high signals on FS T2W images in conjunction with contrastenhanced T1W MRE to differentiate between active inflammatory and chronic fibrotic bowel disease. In our study of 81 patients with Crohn's disease, we showed that the use of gadolinium-enhanced interstitial-phase T1W images plus FS T2W for assessing edema, as a measure of inflammation and disease activity, provided a high degree of accuracy compared to other measures of disease activity based on the combination of available endoscopy, biopsy, or surgical pathology (39) . Although other studies have examined the correlation between the disease activity and MRE findings (36, 38, 40) , the significance of the recently improved, high-quality FS single-shot T2W imaging is only now becoming fully appreciated. Technically, the single-shot T2W images are easy to acquire and are extremely robust, providing a consistent image quality that is resistant to motion deterioration and artifacts from gas or surgical clips (21) . Interestingly, the discordance reported between MRE and endoscopy or biopsy has helped to further demonstrate what has been shown previously on pathological specimens: that the mucosal evaluation by endoscopy, capsule endoscopy, and biopsy may significantly under-represent submucosal disease compared to surgical specimens (37) . Conversely, small bowel MRE is insensitive to early changes of Crohn's disease restricted to only the mucosa (28) . The combination of optical methods with MRE provides a comprehensive evaluation of early disease affecting the mucosa (endoscopy, capsule endoscopy, and biopsy) and more extensive disease affecting the submucosa and mesentery.
The drawback of MRE is that the expertise and availability of examinations are still somewhat limited. These may constitute the main limitation of MRE at this time. Further, an MRE study requires approximately 30 min. While this compares favorably to fluoroscopic studies (SBFT or enteroclysis), it is approximately twice as long as the room time for a CT scan. However, when considering the entire length of the examination, starting with any prior bowel preparation and consumption of pre-scanning oral contrast, the differences in room time between MRE and CT become less important. For very young children and for patients with claustrophobia, sedation may be required prior to performing an MRE study. Absolute contraindications to MRE include metallic fragments in the orbits. MRE can provide a measurement of disease activity that impacts the therapeutic decision pathway, including medical and surgical management (Table 3) . MRE may also be used prior to capsule endoscopy to provide information on the transmural disease location and extent and to detect bowel stenoses or obstructions that may contraindicate capsule endoscopy. fat suppression (a, c) . Additionally, the distal ileum is tethered and strictured in the right lower quadrant on coronal delayedphase contrast-enhanced T1W 3D GRE (e, arrow). This causes dilation and partial obstruction of left lower quadrant bowel segments on the coronal T2W image (f, arrowheads). Coronal fat-suppressed coronal T2W image shows several fluid-filled fistulae extending to adjacent ileal loops (g, arrow). Tethering and fistulae are indicative of chronic disease, but the abnormal signal on fat-suppressed T2W images shows the overlay of marked active inflammation. These findings led to the use of immunomodulatory therapy to treat the active disease with longitudinal MRE to provide objective monitoring of the treatment response, prior to re-consideration of surgical intervention for the chronic disease. A 56-year-old female with inflammatory bowel disease. Coronal thick-section single-breath-hold T2W MR cholangiopancreatography (a) demonstrates marked, irregular dilatation and beading of the intrahepatic biliary system. Axial postcontrast delayed-phase T1W 3D GRE image (b) demonstrates irregular beading of regional foci of peripheral intrahepatic bile ducts and also shows the coexistent changes of chronic liver disease. The features of chronic liver disease are, in this case, characteristic of primary sclerosing cholangitis that includes caudate hypertrophy (b, arrowheads) and early hepatic fibrosis along the periphery of the right hepatic lobe. This case illustrates the ability to use MRI for comprehensive digestive system evaluation in the setting of inflammatory bowel disease to provide concurrent diagnostic evaluation of the liver, in addition to evaluation of the bowel and adjacent soft tissues.
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Comparison of MRE to disease activity index
Crohn's disease activity measurements are predominantly subjective measurements. They include physician global assessment, Harvey-Bradshaw Index, Crohn's Disease Activity Index (CDAI) and Pediatric Crohn's Disease Activity Index (PCDAI) (41-43). As expected, comparing objective measures of disease inflammation with MRE to subjective measures of clinical activity has resulted in conflicting data.
Multiple studies have demonstrated no correlation between MRE findings and CDAI (24, 32, 44, 45) . Meanwhile, other studies have demonstrated a correlation between MRE and CDAI (33, 46, 47) and a correlation between MRE and laboratory markers of inflammation (erythrocyte sedimentation rate/C-reactive protein) (41-43). Only two pediatric studies compared MRE to PCDAI, one demonstrating a statistically significant correlation between disease on MRE and PCDAI (48) and the other demonstrating no correlation between MRE and PCDAI (49) .
Subjective clinical activity measurements do not necessarily reflect mucosal findings, and studies that have used them show discordance between inflammation on endoscopy and subjective activity index measurements.
Comparison of MRE to VCE
VCE visualizes the mucosa throughout the entire small intestine with the use of a wireless video capsule. Three studies, each with approximately 20 patients, compared MRE to VCE for the detection of intestinal lesions (36, 50, 51) . All three studies concluded that both MRE and VCE identified diseased small bowel; however, VCE was better at identifying small aphthous lesions and often identified more lesions (36) , which agrees with our contention that MRE is insensitive to early mild disease restricted to the mucosa.
Comparison of MRE to SBFT/ conventional enteroclysis
Historically, SBFT has been recommended for the evaluation of the small bowel to detect both ulceration and strictures in Crohn's disease. Gourtsoyiannis et al. (52) published the largest study comparing MRE (utilizing MR-enteroclysis) to SBFT in 52 Crohn's disease patients. MRE (with MR-enteroclysis) and SBFT were in full agreement in revealing, localizing, and estimating the length of bowel involved. MRE (with MR-enteroclysis) was poor at detecting superficial ulcers but performed well in identifying deep ulcers and stenosis.
These earlier studies were likely limited by the use of older sequences because they did not yet have access to the most optimized T1W and T2W techniques (16, 17, 39) . Current MRE imaging (without MR-enteroclysis) yields significant improvements over fluoroscopic techniques (53) .
Comparison of MRE to CT
Concerns over radiation risks may lead to the under-utilization of CT for the longitudinal management of Crohn's disease. There is a clinical need to optimize the use of cross-sectional imaging that is at the same time safer than and at least as diagnostic as CT. MRE meets that need by providing a safe, non-ionizing technology that can be obtained when required and without additive or long-term harm. In addition, evolving experience is showing that MRE may more accurately describe the submucosal pathology of transmural Crohn's disease, including detecting and quantifying inflammation, fibrotic disease, and other intraabdominal complications, compared to other diagnostics, including CT (Table  1) . A particular diagnostic strength of MRE over CT is the ability to differentiate inflammation from fibrosis within the submucosa of the bowel wall and in the peri-enteric tissues (Tables 1 and  2 ). MRE can show extra-intestinal disease, including bowel obstruction, abscesses, webs, tethering, and fistulae. These disease processes may be visualized on MRE with less dependence on enteroclysis-level bowel distension as is necessary for optimal CT, representing an additional important technical advantage of MRE.
The advantages of CT include its availability and a slight cost differential, although the overall cost-benefit balance is a key measure that remains incompletely evaluated. Studies comparing MRE to CT for the evaluation of small bowel pathology have indicated similar sensitivities in some studies (53, 54) , better sensitivity for CT in one study (55) , and better sensitivity for MRE in a fourth study (56). As we discussed for SBFT, this variety of results can be attributed to the fact that these studies were performed without the advantages of current, optimized MRE techniques.
Comparison of MRE to surgical resection specimens
The gold standard of evaluating MRE findings remains comparison to surgical specimens. Punwani et al. (18) evaluated MRE prior to surgical resection in Crohn's disease (7 fibrostenotic disease and 11 ileal disease unresponsive to treatment). Their results suggest that increased mural thickness and high mural signal intensity reflect the histological features of small bowel inflammation in Crohn's disease. The enhancement pattern differed in fibrostenotic compared to inflammatory tissue, with homogenous enhancement more often observed in inflammation and layered/non-homogenous enhancement visualized in fibrostenotic disease. They concluded that MRE images correlated with the histological examination of surgical specimens and validated the MRE findings against matched histology specimens.
Summary of MRE findings in Crohn's disease
The MRE technique has evolved to produce reproducible, high-quality examinations of the small and large bowel to a degree that significantly advances its sensitivity and specificity in detecting Crohn's disease changes. Much of the comparative literature on MRE was published before the development of optimized techniques, and this accounts for the wide range of results in these studies. In our recent experience, CT does not match MRE for producing the soft tissue contrast necessary to reliably delineate between inflammation and chronic changes related to fibrosis; both processes may look identical on CT. On MRE, the T2 signal increases with inflammation and edema, a marker of active Crohn's disease (22, 39) . The use of singleshot T2 combined with fat suppression employing the SPAIR technique is critical to optimize the sensitivity and specificity of MRE for diagnosing active Crohn's disease (21, 22) ; the majority of earlier publications either did not use FS T2 or did not use the SPAIR technique. Other forms of fat suppression, using simple inversion recovery or chemical shift spoiling, will be affected by higher noise, less uniform fat suppression, or increased through-plane motion sensitivity to bowel peristalsis.
MRE does not detect mild, early disease limited to the mucosa. This accounts for the different results when comparing endoscopic, biopsy and capsule techniques, which only see mucosal disease. However, submucosal and deeper disease is often under-represented on endoscopic examinations but detected by MRE.
Recommendations for clinical applications of MRE in Crohn's disease
MRE can aid in the clinical management of Crohn's disease and provide a more complete picture of the disease burden. The complementary use of MRE with mucosal visualization and biopsy can lead to better management decisions and therapeutic options. MRE can provide a non-invasive longitudinal measure of disease activity and a measure of submucosal fibrosis. It is expected that MRE will improve the utilization of medical and surgical treatments and improve outcomes while decreasing radiation risks from repeated CT scans. Specifically, MRE may be used in clinical applications in Crohn's disease for the following: 1) Evaluation of the extent of small bowel disease at diagnosis 2) Evaluation of disease burden in symptomatic patients to direct therapeutic management 3) Evaluation of fibrostenotic disease, which may respond better to surgery than to escalation of medical therapy 4) Confirmation of clinical remission and consideration for escalation of medical therapy if there is persistent submucosal disease despite clinical remission 5) Evaluation of intra-abdominal complications, including fistulae, tethering, stenosis, and abscesses 6) Evaluation of perianal disease
Research applications of MRE in
Crohn's disease MRE presents numerous translational research opportunities, including the study of the pathogenesis of penetrating/stricturing disease and investigating the mechanisms related to the clinical symptoms of diarrhea and pain. Longitudinal documentation of patients using MRE will yield insights into the nature of submucosal inflammation and its relationships to mucosal disease, fibrostenotic disease, fat wrapping, and changes that occur with medical treatment, including the potential role of medical management in altering the natural course of Crohn's disease. MRE may also be used to monitor fibrosis, which will allow the evaluation of potential therapeutic remodeling of the fibrotic bowel wall, a phenomenon that remains not fully explored. Obstruction is defined as marked dilation of bowel above the diseased segment. MRE, magnetic resonance enterography; E, bowel wall thickening and enhancement on post-gadolinium T1W images; T2hi, high signal intensity in or around the thickened bowel wall, indicative of edema and active inflammatory disease; T2lo, low, normal range, signal intensity in or around the thickened bowel wall, showing no edema and associated with quiescent disease.
